European Commission authorises third safe and effective vaccine against COVID-19

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by AstraZeneca, the third COVID-19 vaccine authorised in the EU.

This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States.

The President of the European Commission, Ursula von der Leyen, said: “Securing safe vaccines for Europeans is our utmost priority. With the AstraZeneca vaccine now authorized, 400 million additional doses will be available in Europe. I expect the company to deliver these doses as agreed, so that Europeans can be vaccinated as soon as possible. We will continue doing all we can to secure more vaccines for Europeans, our neighbours and our partners worldwide.

Stella Kyriakides, Commissioner for Health and Food Safety, said: With this newly authorised vaccine, our portfolio continues to take shape. Our EU Vaccines Strategy has always aimed to have a vaccine portfolio that is broad and diverse, with different technologies used, to maximise our chances of providing safe and effective vaccines to citizens as soon as possible. The European Medicines Agency’s authorisation today is another step towards delivering on this promise. The Commission continues to work around the clock to secure more vaccines for Europe and our international partners. We are leaving no stone unturned in our fight against this pandemic.”

The AstraZeneca vaccine will be given to adults aged 18 years and older for preventing COVID-19. The vaccine causes the immune system (the body’s natural defences) to produce antibodies and specialised white blood cells that work against the virus, so giving protection against COVID-19. People vaccinated will receive two injections of the AstraZeneca vaccine.

According to EMA, most of the participants in the studies were between 18 and 55 years old. There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group. However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines; as there is reliable information on safety in this population, EMA’s scientific experts considered that the vaccine can be used in older adults. More information is expected from ongoing studies, which include a higher proportion of elderly participants.

On the basis of EMA’s positive opinion, the Commission has verified all the elements supporting the marketing authorisation and consulted Member States before granting the conditional marketing authorisation.

The AstraZeneca vaccine is based on an adenovirus, a harmless virus which delivers the ‘instructions’ from the virus that causes COVID-19.This allows the body’s own cells to make the protein unique to the COVID-19 virus. The person’s immune system recognises that this unique protein should not be in the body and responds by producing natural defences against infection by COVID-19.

Next steps

According to the contract signed with the European Commission on 27 August 2020, AstraZeneca will deliver the total amount of 400 million doses throughout 2021. These will add to the 600 million doses of the vaccine by BioNTech-Pfizer and the 160 million doses of the vaccine by Moderna. 

Background

A conditional marketing authorisation (CMA) is an authorisation of medicines on the basis of less complete data required for a normal marketing authorisation. Such a CMA may be considered if the benefit of a medicine’s immediate availability to patients clearly outweighs the risk linked to the fact that not all the data are yet available. However it also ensures that this COVID-19 vaccine meets the EU standards, as for all other vaccines and medicines.

Once a CMA has been granted, companies must provide within certain deadlines further data including from ongoing or new studies to confirm that the benefits continue to outweigh the risks. CMAs are foreseen in the EU legislation specifically for public health emergencies and is considered the most appropriate regulatory mechanism in this pandemic for granting access to all EU citizens and for underpinning mass vaccination campaigns.

AstraZeneca submitted an application for a CMA for their vaccine to EMA on 11 January 2021. However, assessment already started beforehand. EMA had started assessing non-clinical data from laboratory studies in October 2020 and updated its rolling review end of December 2020 on the vaccine’s safety, effectiveness and quality. This rolling review and the assessment of the CMA application allowed EMA to quickly conclude on the safety, effectiveness and quality of the vaccine. EMA recommended granting the conditional marketing authorisation as the benefits of the vaccine outweigh its risks.

The European Commission has verified whether all necessary elements – scientific justifications, product information, educational material to healthcare professionals, labelling, obligations to marketing authorisation holders, conditions for use, etc. – were clear and sound. The Commission also consulted the Member States, as they are responsible for the vaccines marketing and the use of the product in their countries. Following the Member States’ endorsement and on the basis of its own analysis, the Commission decided to grant the conditional marketing authorisation.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Tools of asset development: Renewable Energy Projects case

How the massive plan to deliver the COVID-19 vaccine could make history – and leverage blockchain like never before

President von der Leyen’s State of the Union Address: charting the course out of the coronavirus crisis and into the future

Why capital markets have no more reservetions about Eurozone

OECD tells Eurozone to prepare its banks for a tsunami coming from developing countries

China in my eyes

Voice tech and the question of trust

My twin from Guangzhou

Business is a crucial partner in solving the mental health challenge

One third of poorer countries face both undernutrition and obesity: WHO report

Eurozone in trouble after Nicosia’s ‘no’

New energy security framework will help meet growing needs in East Africa, sustainably – UN economic wing

A shortened EU Summit admits failures, makes risky promises

Excise duties: Commission welcomes agreement on rules governing alcohol

COVID-19 lessons learnt: boosting EU civil protection

These are the countries best prepared for the fight against cancer

UN chief welcomes Taliban’s temporary truce announcement, encourages all parties to embrace ‘Afghan-owned peace’

Businesses are thriving, societies are not. Time for urgent change

GSMA Mobile 360 Series – MENA in Dubai, in Association with The European Sting

Korea should adapt its migration programmes to ensure continued success in the face of expected challenges

World must do more to tackle ‘shadowy’ mercenary activities undermining stability in Africa, says UN chief

Risks rising in corporate debt market

Military Medicine and its Relationship with Antibiotic Therapy

LGBTQI+ and medicine: are we prepared to deliver dignified and non-discriminatory health care?

ICC Appeals Chamber acquits former Congolese Vice President Bemba from war crimes charges

New labour laws in Qatar benefiting migrant workers a ‘momentous step forward’: ILO

Drinking water: new plans to improve tap water quality and cut plastic litter

Commission tries to solidify the EU statistical system

COP21 Breaking News_03 December: Argentina Accepts KP Amendment

On eve of Gaza border protest anniversary, UN’s top humanitarian official for Palestine calls for calm

What matters most to young Europeans?

Parliament pushes for cleaner cars on EU roads by 2030

How drones can help rural Africa take flight

Art has the power to change the world, says this renowned Iranian muralist

Spending on health increase faster than rest of global economy, UN health agency says

nCoV: An Emerging Respiratory Infection

What cybersecurity professionals can learn from triathletes

Russia accepts what the EU has to offer and settles to negotiate with Ukraine

New Erasmus: more opportunities for disadvantaged youth

GSMA Mobile 360 – MENA Dubai on 26-27 November 2019, in association with The European Sting

Businesses are lacking moral leadership, according to employees

Antitrust: Commission imposes interim measures on Broadcom in TV and modem chipset markets

Japan’s population is shrinking by a quarter of a million people every year

This robot boat delivered a box of oysters in a breakthrough for unmanned shipping

Key elements of the EU-China Comprehensive Agreement on Investment

“A global threat lies ahead worsened after the EU’s green light to the Bayer-Monsanto merger”, a Sting Exclusive by the President of Slow Food

Car-free day – and the other 364 days of the year

The global liberal order is in trouble – can it be salvaged, or will it be replaced?

The JADE Spring Conference 2017 is casting its shadows before

Entrepreneurship in a newly shaped Europe: what is the survival kit for a young Catalan and British entrepreneur in 2018?

Draghi tells the EU Parliament his relaxed policies are here to stay

3 charts to help you understand the American shale boom

Where do health literacy and health policy meet?

How listening to patients could change the way we tackle cancer

How the diaspora is helping Venezuela’s migration crisis

Car emissions: MEPs set end on gap between lab and real driving emission tests

New El Salvador law, a victory for forced displacement victims: UN refugee agency

4 ways the way we make things can change for a sustainable world

Millennials (and Gen X) – Here are the steps you should take to secure your financial future

Trump systematically upsets global order and trade: Where does this end?

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s